Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M266Revenue $M4.4Net Margin (%)-967.2Z-Score-3.0
Enterprise Value $M283EPS $-0.8Operating Margin %-1,332.5F-Score2
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-1,330.0Higher ROA y-yN
Price/Book16.410-y EBITDA Growth Rate %34.0Quick Ratio3.6Cash flow > EarningsY
Price/Sales45.15-y EBITDA Growth Rate %62.8Current Ratio3.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-70.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-258.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M72.2ROI % (ttm)-119.2Gross Margin Increase y-yY

Gurus Latest Trades with BTX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

BTX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-07-22Buy370,000$2.6536.23 view
WEST MICHAEL DCEO 2014-07-22Sell270,000$2.6536.23 view
Peabody RobertSr. VP, COO, and CFO 2014-07-22Sell100,000$2.6536.23 view
TEW WILLIAM P PHDChief Commercial Officer 2014-06-17Sell30,000$3.0717.59 view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-06-16Buy1,000,000$2.544.4 view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2014-05-16Sell300,000$2.4547.35 view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-05-16Buy300,000$2.4547.35 view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-05-08Buy300,000$2.4447.95 view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2014-05-08Sell300,000$2.4447.95 view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-05-01Buy2,000,000$2.5243.25 view

Press Releases about BTX :

    Quarterly/Annual Reports about BTX:

    News about BTX:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: BTX, CWST, BKSC, STAG Jun 27 2011 
    Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 


    More From Other Websites
    9:03 am BioTime's aubsidiary Cell Cure Neurosciences demonstrates the safety and efficacy of OpRegen... Sep 17 2014
    BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Demonstrates the Safety and Efficacy of... Sep 17 2014
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Sep 17 2014
    BIOTIME INC Files SEC form 8-K, Other Events Sep 15 2014
    BioTime, Inc.’s Subsidiary OncoCyte Corporation and Abcodia to Collaborate on Breast Cancer... Sep 15 2014
    BioTime, Inc.’s Subsidiary OncoCyte Corporation and Abcodia to Collaborate on Breast Cancer... Sep 15 2014
    BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement Sep 11 2014
    BioTime Subsidiary, Asterias Biotherapeutics, and Cancer Research UK and Cancer Research Technology... Sep 11 2014
    BioTime Subsidiary, Asterias Biotherapeutics, and Cancer Research UK and Cancer Research Technology... Sep 11 2014
    Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial... Sep 11 2014
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Sep 10 2014
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Sep 09 2014
    BioTime CEO Dr. Michael D. West to Present at Rodman & Renshaw 16th Annual Healthcare Conference Sep 09 2014
    Asterias Biotherapeutics Announces Record Date for Distribution of BioTime Warrants to Holders of... Sep 04 2014
    BioTime's AST-OPC1 Cleared by FDA for Phase I/IIa Study Aug 28 2014
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Aug 28 2014
    BioTime to Collaborate With the University of Wisconsin and Louvain University in Test of... Aug 28 2014
    BioTime Subsidiary Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a... Aug 27 2014
    BIOTIME INC Files SEC form 8-K, Other Events Aug 27 2014
    Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of... Aug 27 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK